The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP

The three related 160-kDa proteins, SRC-1, TIF-2 and RAC-3, were initially identified as factors interacting with nuclear receptors. They have also been reported to potentiate the activity of other transcription factors such as AP-1 or NF-κB. The aim of this work was to identify whether SRC-1 interf...

Descripción completa

Detalles Bibliográficos
Autores: Dennler, S., Pendaries, V., Tacheau, C., Costas, M.A., Mauviel, A., Verrecchia, F.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2005
País:Argentina
Institución:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
Repositorio:Biblioteca Digital (UBA-FCEN)
Idioma:inglés
OAI Identifier:paperaa:paper_09509232_v24_n11_p1936_Dennler
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_09509232_v24_n11_p1936_Dennler
Access Level:acceso abierto
Palabra clave:p300
Smad
SRC-1 TGF-β
E1A protein
messenger RNA
oncoprotein
protein p300
recombinant transforming growth factor beta1
Smad protein
Smad3 protein
Smad4 protein
steroid receptor coactivator 1
virus protein
DNA binding protein
histone acetyltransferase
nuclear protein
transactivator protein
transcription factor
transforming growth factor beta
Adenovirus
apoptosis
article
dermis
DNA binding
gel mobility shift assay
gene overexpression
genetic transcription
genetic transfection
human
human cell
nonhuman
Northern blotting
plasmid
priority journal
protein protein interaction
reporter gene
signal transduction
skin fibroblast
cell line
fibroblast
male
metabolism
newborn
physiology
skin
Adenoviridae
Mammalia
Cell Line
DNA-Binding Proteins
Fibroblasts
Genes, Reporter
Histone Acetyltransferases
Humans
Infant, Newborn
Male
Nuclear Proteins
Plasmids
Signal Transduction
Skin
Smad Proteins
Trans-Activators
Transcription Factors
Transcription, Genetic
Transfection
Transforming Growth Factor beta
Descripción
Sumario:The three related 160-kDa proteins, SRC-1, TIF-2 and RAC-3, were initially identified as factors interacting with nuclear receptors. They have also been reported to potentiate the activity of other transcription factors such as AP-1 or NF-κB. The aim of this work was to identify whether SRC-1 interferes with the TGF-β/Smad signaling pathway, and if so, to identify its underlying mechanisms of action. Using transient cell transfection experiments performed in human dermal fibroblasts with the Smad3/4-specific (SBE) 4-lux reporter construct, as well as the human PAI-1 promoter, we determined that SRC-1 enhances TGF-β-induced, Smad-mediated, transcription. Likewise, SRC-1 overexpression potentiated TGF-β-induced upregulation of PAI-1 steady-state mRNA levels. Using a mammalian two-hybrid system, we demonstrated that SRC-1 interacts with the transcriptional co-activators p300/CBP, but not with Smad3. Overexpression of the adenovirus E1A oncoprotein, an inhibitor of CBP/p300 activity, prevented the enhancing effect of SRC-1 on Smad3/4-mediated transcription, indicating that p300/CBP may be required for SRC-1 effect. Such hypothesis was validated, as expression of a mutant form of SRC-1 lacking the CBP/p300-binding site failed to upregulate Smad3/4-dependent transcription, while full-length SRC-1 potentiated p300-Smad3 interactions. These results identify SRC-1 as a novel Smad3/4 transcriptional partner, facilitating the functional link between Smad3 and p300/CBP. © 2005 Nature Publishing Group All rights reserved.